Alterations in the thalamic reticular nucleus of rats neonatally treated with thyroxine

Salas, Manuel; Torrero, Carmen; Regalado, Mirelta; Carrillo, Porfirio.
Bol. estud. méd. biol ; 41(1/4): 3-7, ene.-dic. 1993. tab
Artículo en Inglés | LILACS | ID: lil-135043

Documentos relacionados

  1. Intravenous Levothyroxine for Unstable Brain-Dead Heart Donors.
  2. Intravenous Levothyroxine for Unstable Brain-Dead Heart Donors.
  3. Intravenous Levothyroxine for Unstable Brain-Dead Heart Donors.
  4. Intravenous Levothyroxine for Unstable Brain-Dead Heart Donors. Reply.
  5. Metabolic changes associated with two endocrine abnormalities in dogs: elevated fructosamine and low thyroxine.
  6. Molecular Basis for the Remarkably Different Gas-Phase Behavior of Deprotonated Thyroid Hormones Triiodothyronine (T3) and Reverse Triiodothyronine (rT3): A Clue for Their Discrimination?
  7. Ionic Levothyroxine Formulations: Synthesis, Bioavailability, and Cytotoxicity Studies.
  8. Should we depend on reference intervals from manufacturer package inserts? Comparing TSH and FT4 reference intervals from four manufacturers with results from modern indirect methods and the direct method.
  9. Recommendations for managing patients with hypothyroidism.
  10. Low serum free triiodothyronineis level predicts worse outcome of patients with severe fever with thrombocytopenia syndrome.